Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Cash (2024 - 2025)

Connect Biopharma Holdings' Change in Cash history spans 2 years, with the latest figure at -$2.8 million for Q3 2025.

  • For Q3 2025, Change in Cash rose 77.96% year-over-year to -$2.8 million; the TTM value through Sep 2025 reached -$53.0 million, changed N/A, while the annual FY2023 figure was $26.7 million, N/A changed from the prior year.
  • Change in Cash for Q3 2025 was -$2.8 million at Connect Biopharma Holdings, up from -$7.1 million in the prior quarter.
  • Across five years, Change in Cash topped out at $8.4 million in Q1 2024 and bottomed at -$30.5 million in Q1 2025.